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Abstract 
In the present work, we studied the effects of phenoxyl radicals, generated by tyrosinase-catalyzed oxidation of a phenolic antitumor 
drug, Etoposide (VP-16), on a purified dog kidney Na+/K+-ATPase by characterizing interactions of VP-16 phenoxyl radicals with the 
enzyme's SH-groups by ESR and correlating the loss of the enzymatic activity with the oxidation of its SH-groups, and oxidation of 
VP-16. VP-16/tyrosinase caused inhibition of Na+/K+-ATPase which was dependent on the incubation time and concentration of
tyrosinase. The inhibition of Na+/K+-ATPase was accompanied by a decrease of DTNB (5,5'-dithiobis-(2-nitrobenzoic acid)-titratable 
SH-groups. In the presence of Na+/K+-ATPase, a typical ESR signal of the VP-16 phenoxyl radical could be observed only following a 
lag period the duration of which was proportional to the concentration of the Na+/K+-ATPase added. Our HPLC measurements 
demonstrated that Na+/K+-ATPase protected VP-16 against tyrosinase-catalyzed oxidation. Combined these results suggest hat 
redox-cycling of VP-16/VP-16 phenoxyl radical by SH-groups of Na+/K+-ATPase occurred. Ascorbate which is known to reduce the 
VP-16 phenoxyl radicals, protected the enzyme against inactivation, prevented oxidation of the enzyme's SH-groups. Reduction of VP-16 
phenoxyl radicals by ascorbate was directly observed by the semidehydroascorbyl radical signal in the ESR spectra. VP-16 phenoxyl 
radical-induced oxidation of sulfhydryls and inhibition of the Na--/K+-ATPase may be responsible for at least some of its clinical side 
effects (e.g., cardiotoxicity) which can be prevented by ascorbate. 
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1. In t roduct ion  
Highly reactive hydroxyl radicals and their lipophilic 
membrane counterparts, lipid alkoxyl and peroxyl radicals, 
generated by oxidative stress may attack different amino 
acid residues of cytosolic and membrane proteins resulting 
in a relatively indiscriminative oxidative modification 
and/or  irreversible inactivation of enzymes, receptors, 
channel-formers and structural proteins [1,2]. In contrast, 
low energy phenoxyl radicals formed as intermediates in
reactive radical scavenging by phenolic antioxidants, are 
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assumed to be relatively stable [3,4]. While phenoxyl 
radicals of natural phenols (e.g., vitamin E) under normal 
conditions are not reactive towards iipids, DNA and most 
amino acid residues, they readily interact with important 
physiological reductants, uch as ascorbate and thiols [5,6]. 
Moreover, phenoxyl radicals formed from some phenolic 
compounds were shown to oxidize both small molecular 
weight thiols and protein sulfhydryls [7]. In particular, a 
widely clinically used phenolic antitumor drug, Etoposide, 
(VP-16) is oxidized to phenoxyl radicals in the presence of 
tyrosinase or peroxidase [8,9]. The radicals formed directly 
oxidize ascorbate and diverse thiols both in model systems 
and in tissue homogenates [10,11]. The redox-cycling of 
VP-16/VP-16 phenoxyl radical may significantly deplete 
endogenous antioxidants etting the stage for oxidative 
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stress [11]. Previously, we have demonstrated that VP-16 
phenoxyl radical-dependent oxidation of critical sulfhydryls 
is responsible for activation of CaZ+-release channels and 
inhibition of Ca>-ATPase in sarcoplasmic reticulum 
membranes [12] which may be, at least in part, responsible 
for clinically well-known cardiotoxic side-effects of VP-16 
[131. 
The energy dependent exchange of cytoplasmic Na ÷ 
for extracellular K ÷ in mammalian cells is due to a 
membrane bound sodium pump, the Na+/K+-ATPase [14]. 
The enzyme, located in the plasma membrane of all animal 
cells, is a member of a family of ion-translocating AT- 
Pases that share highly homologous catalytic subunits. 
Na÷/K+-ATPase consists of two membrane spanning 
polypeptides, an alpha subunit of 112-kDa and a beta-sub- 
unit, which is a glycoprotein of 35-kDa. The catalytic 
properties are associated with the alpha-subunit, which has 
the binding domain for ATP and the cations [15]. The 
enzyme contains more than 20 sulfhydryl groups which 
differ significantly in their reactivity and accessibility to 
SH-reagents [16]. Even though the exact role of the SH- 
groups is not known, modification of some of them causes 
the inhibition of the Na-/K+-ATPase. Na+/K+-ATPase, 
is a potential target for selective attack by phenoxyl radi- 
cals. While Na+/K+-ATPase has been demonstrated to be 
highly sensitive to oxidative stress [17,18], the role of the 
enzyme's functionally essential SH-groups in its oxidative 
damage has not been definitively established. 
In the present work, we studied the effects of phenoxyl 
radicals, generated by tyrosinase-catalyzed oxidation of 
VP-16, on a purified dog kidney Na+/K+-ATPase by 
characterizing interactions of VP-16 phenoxyl radicals with 
the enzyme's SH-groups by ESR and correlating the loss 
of the enzymatic activity with the oxidation of its SH- 
groups, and oxidation of VP- 16. 
2. Materials and methods 
2.1. Materials 
2.2. Assay of SH-groups in Na +/ K +-ATPase 
Concentration of sulfhydryls in Na+/K+-ATPase was 
determined using 5,5'-dithiobis-(2-nitrobenzoic acid), 
(DTNB), Ellman reagent [20]. Absorbance spectra were 
recorded on a Hitachi-557 spectrophotometer under con- 
stant emperature control. The DTNB blank was subtracted 
from the reference beam and absorbance was measured at 
412 nm. For correction of the scattering input in the 
absorbance measured, optical density at 550 nm was sub- 
tracted from that at 412 nm. In order to identify free 
SH-groups of the enzyme, aliquots containing 50-100 /zg 
of protein were preincubated 30 min at 37°C in 10 mM 
potassium-phosphate buffer (pH 8.5) containing 1 mM 
EDTA and 8 M urea. In order to prevent he interference 
of VP-16 radicals with the reagents in the assay medium, 
samples were diluted 10-fold and tyrosinase activity was 
inhibited by denaturing reagent (8 M urea). 
2.3. Protein concentration measurement 
Protein concentration i Na+/K+-ATPase was deter- 
mined by the Lowry method with bovine serum albumin as 
a standard [19] and by protein assay kit (Bio-Rad). 
2.4. Tyrosinase + VP-16 induced oxidation of Na +/ K +- 
ATPase 
The ATPase protein was incubated 5-60 min at 37°C in 
the presence of different concentrations of mushroom ty- 
rosinase and VP-16. Reaction was started by the addition 
of VP-16 (25-200 /zM) to incubation medium containing 
80 mM potassium-phosphate buffer (pH 7.4), 50 /zM 
DFO, to chelate metal ions, tyrosinase (1-3.8 U /  /xl) and 
0.3 mg/ml Na+/K+-ATPase. Aliquots were taken to 
assay ATPase activity and content of SH-groups 
Na+/K+-ATPase. 
2.5. Tyrosinase-catalyzed oxidation of VP-16 in the pres- 
ence and in the absence of Na +/ K +-ATPase 
Methanol (HPLC) grade was purchased from Aldrich 
(Milwaukee, WI). Deferoxamine mesylate (DFO) was pur- 
chased from Ciba (NJ). Protein assay kit was obtained 
from Bio-Rad (Hercules, CA). VP-16 was a generous gift 
from Bristol-Myers Squibb (Syracuse, NY). Tyrosinase 
from mushroom and other chemicals were obtained from 
Sigma (St. Louis, MO). 
Na+/K+-ATPase from outer medulla of canine kidney 
was prepared as previously described [18]. Hydrolytic 
activity of Na+/K+-ATPase was determined as y-p32-re- 
lease from radiolabelled ATP in the medium containing 
NaCI 100 mM, KCI 25 mM, MgC12 3 mM, ATP 2 mM, 
MOPS 30 mM (pH 7.4, 37°C) [18,19]. Specific ATPase 
activity was about 1500 /xmol Pi/mg per h (37°C) and 
was inhibited by 1 mM ouabain by no less than 95%. 
For measurements of VP-16 phenoxyl radical forma- 
tion, VP-16 (200 /zM) and tyrosinase (3.8 U//xl) were 
incubated in 50 mM potassium-phosphate buffer (pH 7.5 at 
25°C), containing DFO 50 /xM in the presence or absence 
of Na+/K--ATPase as described elsewhere [9]. The phos- 
phate buffer was pretreated with Chelex-100 to remove 
possible metal ion contaminants. 
2.6. HPLC assay of VP-16 
Aliquots of the reaction mixture (25/zl) were taken at 
given time intervals and transferred into 0.3 ml of 50% 
aqueous CH3OH. The dispersion thus formed was filtered 
through a C-18 cartridge (1 ml Sep-Pak cartridge, Waters 
Division of Millipore, Millipore, Milford, MA) and the 
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filtrate was used for HPLC assays. HPLC analysis of 
VP-16 was performed on a Shimadzu LC-10A system 
equipped with an LC-600 pump and an M 10A photodiode 
array detector. Separation of the VP-16 oxidation mixture 
on a CI 8 reverse phase column (Ultrasphere ODS, 5 mm 
particle size, 4.6 X 250 mm, Beckman) was carried out 
with a mobile phase of 50% aqueous CH3OH adjusted to 
pH 3.1 with CH3COOH at a flow rate of 1.3 ml/min. 
Under these conditions, the retention time for VP-16 was 
4.6 min. 
2.7. ESR-spectroscopy of VP-16 phenoxyl radicals 
ESR measurements were performed on a JEOL JES- 
RE1X spectrometer at 25°C in gas permeable Teflon tub- 
ing (0.8 mm internal diameter, 0.013 mm wall thickness; 
obtained from Alpha Wire, Elizabeth, N J). The tube ap- 
prox. 10 cm length was filled with 60 ~I of a mixed 
sample, folded twice and placed into an open 3.0 mm 
internal diameter ESR quartz tube in such a way that all of 
the sample was within the effective microwave irradiation 
area. Spectra of VP-16 phenoxyl radicals were recorded at 
335.5 mT - center field, 20 mW - microwave power, 0.05 
mT-  field modulation, 0.03 s - time constant. 
2.8. Measurement of the lag period in the oxidation reac- 
tion of the VP-16 by tyrosinase 
Na+/K+-ATPase was added to the incubation mixture 
containing VP-16, and DFO (time = 0) and the final vol- 
ume was adjusted to 60 /xl with potassium-phosphate 
buffer (pH 7.5 at 25°C). To start the reaction tyrosinase 
was added. The concentrations of Na+/K+-ATPase in 
incubation medium were from 25.0 to 100.0 /xg/ml. The 
lag period was determined as the time between adding 
tyrosinase and the appearance of the VP-16 phenoxyl 
radical ESR spectrum at a signal to noise ratio larger than 
2. 
3. Results 
3.1. VP-16 Phenoxyl radicals in the presence and absence 
of Na +/K +-ATPase 
A characteristic signal of the VP-16 phenoxyl radical 
appeared in the ESR spectra immediately after the addition 
of tyrosinase (Fig. 1). The magnitude of the ESR signal 
increased over 50-60 min of incubation and reached a 
plateau thereafter (Fig. 2A). In the presence of Na+/K +- 
ATPase, the ESR signal of the VP-16 phenoxyl radical 
could be observed only following a lag period the duration 
of which was proportional to the concentration of the 
Na+/K+-ATPase added (Fig. 2 A and B). 
3.2. Effect of Na +/ K +-ATPase on the VP-16 oxidation 
We used an HPLC assay to measure the effect of 
Na+/K+-ATPase on the rate of tyrosinase-catalyzed oxi-
dation of VP- 16. Na +/K +-ATPase protected VP- 16 against 
oxidation (Fig. 3). While in the control (without 
Na+/K+-ATPase) the observed initial rate of the VP-16 
oxidation was 36.4/xM/10 min, the rate decreased to less 
than 1.6 /zM/10 min in the presence of 300 /zg 
Na+/K+-ATPase/ml. This 'lag period' in the VP-16 
oxidation caused by Na+/K+-ATPase was followed by an 
increased rate of oxidation, comparable to that in the 
control. These results in combination with our ESR data 
provide evidence for the recycling of VP-16 via reduction 
of its phenoxyl radicals by Na+/K+-ATPase. 
3.3, Inhibition of Na +/K +-ATPase 
Na+/K+-ATPase was inhibited up to 80% during 60 
min of incubation with VP-16 and tyrosinase (Fig. 4). The 
residual 20% of activity could not be inhibited by in- 
creases in concentrations of VP- 16 and/or tyrosinase. The 
time course of inhibition was linear during the first 10 min 
Control 
(VP-16 + Tyros lnase)  + ATPase  
• ~ . . . .  5 rain 5 min 
+ ATPase  
+ Ascorbate  
~ ~  ..... 25 rain ~ ' "  ~ ' ~ V ~  25 min 
1 mT 
I i 
Fig. 1. ESR spectra of VP-16 phenoxyl radicals, and ascorbyl radicals generated by tyrosinase in the presence and absence of Na+/K+-ATPase (upper 
traces, on the 5th min; lower traces, on the 25th min). Samples contained: VP-16 (200/xM), tyrosinase (3.8 U/~l) ,  deferoxamine (50 /xM), KC1 (80 mM) 
in 50 mM potassium-phosphate buffer (pH 7.5 at 25°C), Na+/K+-ATPase (50 /x/ml), ascorbate 2 mM. ESR conditions: center field 335.5 mT, sweep 
width 5 mT, field modulation 0.05 mT, gain 100 (gain 500 in the measurement of ascorbate radical spectra). 
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Fig. 2. (A) Time-course of ESR signals of VP-16 pbenoxyl radicals 
generated by tyrosinase-catalyzed oxidation of VP-16 in the absence and 
presence of different amounts of Na+/K+-ATPase: 12, control (no 
Na+/K+-ATPase), zx, 50 p.g/ml and O, 100/xg/ml Na+/K+-ATPase. 
(B) Dependence of the lag period in tyrosinase-catalyzed oxidation of 
VP-16 on the concentration of Na+/K+-ATPase. ESR signal measure- 
ments. Experimental conditions were as described in the legend to Fig. 1. 
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Fig. 4. Time-course of Na÷/K+-ATPase activity during its incubation 
with tyrosinase and VP-16. Effect of ascorbate and ATP: O, control (no 
VP-16), zx, complete system; [] plus ascorbate (2 mM); A, plus ATP (3 
mM, no ascorbate). Na ÷/K÷-ATPase 0.3 mg/ml; other conditions were 
as given in the legend of Fig. 1. 
effect on the inactivation of the Na+/K+-ATPase in our 
system (data not shown). Saturation of Na+/K+-ATPase 
with ATP has been shown to prevent he reaction of the 
enzyme with certain SH-modifying reagents [21,22]. At 
saturating concentrations (3 mM), ATP did not protect he 
enzyme against inactivation by VP-I 6/tyrosinase (Fig. 4). 
3.4. Oxidation of SH-groups of Na +/K +-ATPase 
and slowed down progressively at longer times of incuba- 
tion (Fig. 4). The inhibitory effect was proportional to the 
amount of tyrosinase added (Table 1). Neither VP-16 
alone, nor tyrosinase alone yielded any significant inhibi- 
tion of the enzymatic activity (data not shown). Ascorbate 
protected Na+/K+-ATPase against oxidative inactivation 
by VP-16 phenoxyl radicals (see below 3.5). The enzyme 
was equally sensitive to VP-16/tyrosinase-induced oxida- 
tion in the presence of Na ÷ or K ÷ ions suggesting that 
conformational changes caused by ion-binding had no 
Our enzyme preparation contained 14 SH-groups/ 
molecule titratable by DTNB. The enzyme SH-groups 
decreased almost linearly over time in the course of incu- 
bation with VP-16/tyrosinase (Fig. 5). Incubation of 
Na+/K+-ATPase with VP-16 and tyrosinase for 60 min at 
37°C resulted in oxidation of about nine SH-groups. Thus, 
the inhibition of the enzyme was accompanied by a pro- 
nounced ecrease of DTNB-titratable SH-groups (Fig. 5). 
3.5. Effects of ascorbate on the interaction of VP-16 
phenoxyl radicals with Na +/ K +-ATPase 
lOOl 
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Fig. 3. Tyrosinase-catalyzed oxidation of VP-16 in the presence (C)) and 
absence (D) of Na+/K÷-ATPase. Incubation conditions: Na+/K +- 
ATPase (0.3 mg/ml), VP-16 (200 txM); other conditions were as given 
in the legend to Fig. 1. 
Since ascorbate has been shown to reduce VP-16 phe- 
noxyl radicals back to phenols [6] we studied whether it 
could prevent the inactivation of Na+/K+-ATPase by 
VP-16/tyrosinase-induced oxidation. In the presence of 
Table 1 
Dependence of Na+/K+-ATPase activity on tyrosinase concentration 
Tyrosinase 
concentration 
(U/~l) 
Na ÷/K ÷-ATPase activity (% of the control) 
5 min incubation 60 min incubation 
0 97 79 
1.0 90 71 
2.0 85 53 
3.8 77 23 
Incubation conditions: 0.3 mg/ml Na+/K+-ATPase, 80 mM potassium- 
phosphate buffer (pH 7.4 at 37°C), 50 /xM DFO and 200 /xM VP-16. 
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Fig. 5. Time-course of Na+/K+-ATPase thiols content during 
tyrosinase-catalyzed oxidation of VP-16. Effect of ascorbate: C), control 
(no VP-16), ~,  complete system, D, in the presence of ascorbate (2 
mM). Experimental conditions: Na +/K+-ATPase 0.3 mg/ml ;  other con- 
ditions as given in the legend to Fig. 1. 
ascorbate, a typical signal of semidehydroascorbyl radical 
was continuously observable in the ESR spectra for 60 min 
of incubation both in the presence and in the absence of 
Na+/K+-ATPase (Fig. 1). No ESR signals of VP-16 
phenoxyl radicals could be detected up to 60 min of 
incubation. Thus, one-electron reduction of VP-16 phe- 
noxyl radicals by ascorbate resulting in its one-electron 
oxidation intermediate, semidehydroascorbyl radical took 
place. The enzyme activity was effectively protected 
against VP-16/tyrosinase-induced inhibition by the addi- 
tion of excess ascorbate (2 mM) (Fig. 4). The enzyme 
retained 85% activity at 10 rain of incubation in the 
presence of ascorbate (which is close to the 94% activity 
in control). Without ascorbate, the activity decreased to 
55%. In addition, the reduction in the number of SH- 
groups/molecule of Na+/K+-ATPase was also prevented 
in the presence of 2 mM ascorbic acid (Fig. 5). 
4. Discussion 
Exposure of isolated membrane fractions to different 
kinds of reactive oxygen species (. OH, peroxyl and alkoxyl 
radicals, FeO 2+) demonstrated anextremely high sensitiv- 
ity of Na+/K+-ATPase to oxidation [17]. In vivo treat- 
ments associated with the production of oxidative stress 
(e.g., ischemia/reperfusion f the heart, hyperbaric oxy- 
genation, have been also shown to decrease the activity of 
the enzyme [23,24]. Mechanisms of oxidative modification 
of the Na+/K+-ATPase by reactive oxygen species such 
as contribution of annulus lipid oxidation versus protein 
oxidation and specific role of sulfhydryl oxidation remain 
to be elucidated [ 17-19]. 
4.1. VP-16 phenoxyl radicals inhibit Na +/K +-ATPase 
We have shown previously that phenoxyl radicals gen- 
erated from a phenolic antitumor drug, VP-16, react with 
GSH as well as with SH-groups of proteins [11]. While the 
VP-16 radical is reduced in the reaction, the sulfhydryl 
oxidation leads to inhibition of activity of several enzymes, 
including Ca +2 ATPase and the Ca2+-release channel 
[12,25]. Redox-cycling of VP- 16/VP- 16 pbenoxyl radical 
by thiols was suggested to result in cytotoxic effects most 
likely via thiol pumping [11], i.e., a futile depletion of low 
molecular weight hiols and oxidation of protein sulfhydryls 
[26]. 
The reaction of the low energy phenoxyl radicals with 
proteins is selective for the cysteine sulfhydryls [27]. 
Therefore we used the tyrosinase/VP-16 as a model sys- 
tem to elucidate the effects of phenoxyl radicals on 
Na+/K  +-ATPase. The inhibition of the enzyme was clearly 
associated with the tyrosinase-catalyzed activation of VP- 
16. Neither VP-16 nor tyrosinase alone significantly inhib- 
ited the enzyme. In combination, VP-16 and tyrosinase 
inhibited Na+/K+-ATPase in a concentration dependent 
manner. Thus one can suggest hat the inhibition was due 
either to the oxidation of the enzyme SH-groups by the 
phenoxyl radicals or to the binding of the VP-16 oxidation 
products to the enzyme. 
Our results are consistent with the suggestion that phe- 
noxyl radical-mediated oxidation of the enzyme sulfhydryls 
rather than effects of VP-16 oxidation products (e.g., 
o-quinone of VP-16) were involved in inactivation of the 
Na+/K+-ATPase. This conclusion is supported by: (i) 
disappearance of the VP-16 phenoxyl radical ESR signal 
was observed upon addition of Na+/K+-ATPase, (ii) de- 
crease of the enzyme SH-groups in the course of its 
incubation with tyrosinase/VP-16, (iii) decrease in the rate 
of tyrosinase-catalyzed VP-16 oxidation in the presence of 
Na+/K+-ATPase, and (iv) strong protective effect of 
ascorbate (which reduced VP-16 phenoxyl radicals by a 
one electron process accompanied by the formation of 
ESR detectable semidehydroascorbyl radicals) in prevent- 
ing both the loss of enzymatic activity and oxidation of 
SH-groups. Combined our results give evidence that VP-16 
phenoxyl radical-induced oxidation of the Na+/K  +- 
ATPase SH-groups was most likely responsible for the 
enzyme inhibition. 
4.2. VP-16 phenoxyl radical-induced oxidation o[ SH- 
groups of Na +/K +-ATPase 
Na+/K+-ATPase consists of two subunits, c~ and /3, 
which are present in equimolar amounts. The Na+/K  +- 
ATPase dimeric protomer (a functional unit) has a molecu- 
lar mass of about 145-150 kDa [18,27,28]. Based on the 
pronounced ifference in the reactivity toward N-ethyl- 
maleimide and effects on the enzymatic activity, Esmann 
et al. classified SH-groups of Na+/K+-ATPase into three 
categories [29]. In a purified pig kidney Na+/K+-ATPase, 
10-20 sulfhydryl groups have been reported to be avail- 
able for different SH-reagents [15]. At least one of the 
SH-groups is located in the ATP binding site [21,22] 
suggesting that its oxidation can cause inhibition of the 
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enzymatic activity. Kirley et al. identified a DTNB-titrata- 
ble SH-group which was found to be essential for the 
binding of ouabain, a specific inhibitor of Na+/K  +-ATPase 
[30]. Studies of rabbit kidney Na+/K+-ATPase using 
alkylating reagents demonstrated the difference in the sen- 
sitivity of the enzyme in different conformation: E~-con- 
former (induced by binding of sodium) was protected 
against the attack by radiolabelled N-ethylmaleimide by 
ATP, while E~-conformer (resulting from binding of potas- 
sium) was protected by ouabain [31,32]. Modification of 
some SH-groups of the enzyme did not affect the activity, 
suggesting their structural role [29]. In line with this, six 
sulfhydryl groups were identified in beta-subunit of the 
enzyme: two sulfhydryl groups were in reduced form and 
four were involved in disulfide bond formation [33]. 
The time course of the enzyme inhibition by 
tyrosinase-induced VP-16 phenoxyl radicals was linear 
during the first 10 min and slowed down at longer incuba- 
tions. This was most likely caused by the different roles of 
the respective SH-groups in enzyme inactivation. The loss 
of 43% of activity during the first 10 rain was accompa- 
nied by the oxidation of one to two SH-groups/mol of 
enzyme which are likely to be essential for the enzyme 
activity. Oxidation of 3-4 additional SH-groups/moi of 
enzyme lead to the total inhibition of 70% of activity. 
Apparently, the additional sulfhydryls are less important 
for enzyme function. After 60 rain incubation, about nine 
SH-groups were oxidized yielding 80-85% inhibition of 
the enzyme. The residual enzymatic activity was not sensi- 
tive to further enhanced generation of phenoxyl radicals 
provided by increased concentrations of tyrosinase and/or 
VP-16. This low level of activity may be characteristic of 
the enzyme with nine of its fourteen SH-groups modified 
by interactions with the VP-16 phenoxyl radicals which 
may result in different oxidation products (e.g., disulfides, 
mixed sulfides, and sulfoxygenated derivatives). Further 
studies are necessary to elucidate the role(s) of these 
products in catalytic activity. Alternatively, the enzyme 
preparation used may be heterogeneous hence not all the 
enzyme molecules are equally susceptible to the attack by 
the VP- 16 phenoxyl radicals. 
Saturation with ATP did not protect he enzyme against 
inactivation by tyrosinase/VP-16: the time course of the 
Na+/K÷-ATPase inactivation was identical in the pres- 
ence and absence of ATP. Thus, the SH-groups within the 
ATP-binding domain are an unlikely target of phenoxyl 
radicals. 
In order to compare the sensitivity of the two 
Na+/K+-ATPase-conformers to phenoxyl radicals, we 
have substituted potassium for sodium in the incubation 
medium. This substitution had no effect on the loss of the 
enzyme activity in the presence of tyrosinase/VP-16. 
While E l- and E2-conformers have been shown to exert 
different sensitivity to SH-reagents [31,34], VP-16 phen- 
oxyl radicals turned to be equally effective in inhibiting 
the enzyme in these different conformations. 
4.3. Toxicological and pharmacological implications 
VP-16 is frequently used in the US as a first-line drug 
for treating small lung cancer, germ cell tumors, lym- 
phomas, and more recently Kaposi's sarcoma associated 
with AIDS. The drug is also used to treat a variety of 
leukemias including acute nonlymphocytic leukemia [35]. 
Teniposide (VM-26), chemically a close relative of VP-16 
is also a very potent antineoplastic drug. Both VP-16 and 
VM-26 are successfully used not only as single agents but 
also in combination chemotherapy aswell as in concurrent 
chemoradiotherapy [36]. While myelosuppression is the 
major toxic effect of these two drugs, cardio-, pulmonary 
and neurotoxicity are considered significant in limiting 
efficiency and intensification of cancer therapy [36-39]. 
In contrast to anthracycline anticancer drugs, toxic 
side-effects of VP-16 cannot be easily derived from their 
ability to intercalate into mitochondrial respiratory chain 
and to generate oxygen radicals. Instead, high reactivity 
and selectivity of VP-16 phenoxyl radicals toward protein 
SH-groups may be the major contributor to its toxic ef- 
fects. The importance of this reaction is accentuated by our 
results which demonstrated that a single injection of VP- 16 
(10 mg/kg  body weight) considerably decreased the con- 
centration of protein thiols and GSH in some organs of the 
rat. The decrease in total titratable protein thiols occurred 
at the same time as the decrease in GSH concentration 
(Kagan et al., unpublished ata). It is therefore important 
to identify the proteins whose sulfhydryls are sensitive to 
oxidation by VP-16 phenoxyl radicals and which deter- 
mine toxic side-effects of chemotherapy. We suggest hat 
VP-16 phenoxyl radical-induced oxidation of sulfhydryls 
and subsequent inhibition of the Na+/K+-ATPase may be 
responsible for at least some of its clinical side effects. 
Therefore, effective protection of Na+/K+-ATPase by 
ascorbic acid described here could suggest future strategies 
to decrease or prevent side effects of VP-16 and related 
phenolic antitumor drugs. 
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